The 5-HT7 receptor and disorders of the nervous system: an overview. - Wikidata - wikimedia - TriplyDB

The 5-HT7 receptor and disorders of the nervous system: an overview.

The 5-HT7 receptor and disorders of the nervous system: an overview.

http://www.wikidata.org/entity/Q33738349

about

Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.LP-211 is a brain penetrant selective agonist for the serotonin 5-HT(7) receptor Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders Cellular mechanisms of the 5-HT7 receptor-mediated signaling Use of antipsychotics in the treatment of depressive disorders The serotonin receptor 7 and the structural plasticity of brain circuits Update on the development of lurasidone as a treatment for patients with acute schizophrenia Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats.Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT₁A and 5-HT₇ Antagonists in Animal Models Stress Modulation of Opposing Circuits in the Bed Nucleus of the Stria Terminalis.Differential distribution of serotonin receptor subtypes in BNST(ALG) neurons: modulation by unpredictable shock stress Pharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategy Low-basicity 5-HT7 Receptor Agonists Synthesized Using the van Leusen Multicomponent Protocol The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior.Decreased exploratory activity in a mouse model of 15q duplication syndrome; implications for disturbance of serotonin signaling.Pharmacological blockade of serotonin 5-HT₇ receptor reverses working memory deficits in rats by normalizing cortical glutamate neurotransmission 5-HT7 receptors as modulators of neuronal excitability, synaptic transmission and plasticity: physiological role and possible implications in autism spectrum disorders.Sleep disturbance as transdiagnostic: consideration of neurobiological mechanisms.Altered serotonin, dopamine and norepinepherine levels in 15q duplication and Angelman syndrome mouse models The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants.Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.Neuroanatomical dichotomy of sexual behaviors in rodents: a special emphasis on brain serotonin.New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant vortioxetine.Brain serotonergic circuitries Long-lasting beneficial effects of central serotonin receptor 7 stimulation in female mice modeling Rett syndrome Solid-Supported Synthesis and 5-HT7 /5-HT1A Receptor Affinity of Arylpiperazinylbutyl Derivatives of 4,5-dihydro-1,2,4-triazine-6-(1H)-one.The 5-HT(7) receptor in learning and memory.HTR7 Mediates Serotonergic Acute and Chronic Itch 5-HT7 receptor modulates GABAergic transmission in the rat dorsal raphe nucleus and controls cortical release of serotonin Concomitant medication of psychoses in a lifetime perspective.Asenapine in bipolar I disorder: evidence and place in patient management.Long-Term Citalopram Treatment Alters the Stress Responses of the Cortical Dopamine and Noradrenaline Systems: the Role of Cortical 5-HT1A Receptors.Sensitization of restraint-induced corticosterone secretion after chronic restraint in rats: involvement of 5-HT₇ receptors.ADN-1184 a monoaminergic ligand with 5-HT(6/7) receptor antagonist activity: pharmacological profile and potential therapeutic utility.Genetic and biochemical changes of the serotonergic system in migraine pathobiology 5-HT(7) receptor modulators: a medicinal chemistry survey of recent patent literature (2004 - 2009).The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment.Serotonergic agents in the management of cluster headache.Intracerebral transplantation for neurological disorders. Lessons from developmental, experimental, and clinical studies.Palmitoylation of serotonin receptors.

P2860

Q24595389-4C37D2FC-101B-4FAE-A519-5BF1A320E88A Q24602670-5D057D12-32D4-4A5D-BF58-15E76B4BF353 Q24632508-76879034-10A1-4863-B8B1-ED97A31796C5 Q26828436-438FEF7B-918C-4BF1-A569-1F45A119A849 Q26860391-7A32C9AE-C536-46FA-9FF4-0259471C8F5D Q27000420-161901A9-5EA1-4BB8-BB7F-740C7C8C28FF Q27009585-7452CB0B-B3C1-48C5-BF0F-E88B5A58D84D Q28533794-CB49092E-9710-4013-B95C-8E333FF3A067 Q28550792-BEC79774-BA2B-496E-8B9C-DB33B312781F Q30366958-AE42968D-7056-41F8-A772-DA0353BB5064 Q30446175-64999A00-914B-451C-BBEF-B694F60D0E95 Q30468153-B6104940-6F46-4BE1-836E-5679163589D0 Q33685407-0584E174-C213-4BE8-886C-3A70395FEF6E Q33706833-0FA82273-0728-4179-A97B-F4D4DE0D2BD1 Q33778683-1EFB54A0-D57A-4216-9808-FA1CB297C43F Q33942069-CEA58E0F-4E8A-4860-99B3-4781645946DC Q34093279-AACBBD32-822F-4EE3-BBF5-A0C48506C634 Q34195351-A101F8E1-00B7-4B23-BBD5-0B2FEC05FFB5 Q34391238-40F25C3A-662B-4344-94F2-636046F3DDDF Q34497909-DB5CA31D-0329-4E4B-A847-D3774B3AC908 Q34653803-FBF48A5C-DC53-4786-A007-1EC6122E2539 Q34670922-0CEF4BAE-0DC4-48CB-BCEC-7A8878B13FD8 Q34676776-F07A1259-2887-4058-A868-D3075F119F6E Q35237299-4D287BB4-DE86-41FA-B3B3-69959FD91CF8 Q35408368-AA4924B8-DDA1-4C45-9B00-5CD6F6BB5E84 Q35561899-6B7DF1C9-7C70-447C-A5E3-56DDC7E24FEC Q35848311-59510782-7766-4075-AA9B-91A8AC356FD1 Q35951993-6BDBF49F-7421-4710-AA61-7D44E7FA6A00 Q35964136-B9422079-27CF-41EE-A9B4-00E56EF5E09A Q36420453-C2927CD9-C615-43D2-8A55-C4657F6E1F9E Q36515504-18109DB1-BFEE-4DAA-97E5-39640493C135 Q37220477-D795135A-76A5-495D-8254-17EF3A6E4C75 Q37337798-AE5621EC-7C3A-41D0-8ED3-E88B84E2605A Q37585410-BD717443-A312-44CE-93D9-779529FDDCF9 Q37640340-5F2E404E-9671-497C-8217-BA5F5055B052 Q37754465-11E44BB1-E9D8-4D7C-A13E-6366635314A1 Q37826638-D1069D81-A0AB-4BEC-A2D0-939704475A43 Q37832687-0134ECD4-2C80-4392-A01B-6C485284CD08 Q37982705-4E32D177-3FE0-4B43-81EA-6B2CA801FA00 Q38077213-38A67876-1953-4C25-8A20-5A080BD5AB1B

P2860

The 5-HT7 receptor and disorders of the nervous system: an overview.

http://www.wikidata.org/entity/Q33738349

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

The 5-HT7 receptor and disorders of the nervous system: an overview.

@ast

The 5-HT7 receptor and disorders of the nervous system: an overview.

@en

type

label

The 5-HT7 receptor and disorders of the nervous system: an overview.

@ast

The 5-HT7 receptor and disorders of the nervous system: an overview.

@en

prefLabel

The 5-HT7 receptor and disorders of the nervous system: an overview.

@ast

The 5-HT7 receptor and disorders of the nervous system: an overview.

@en

P1433

Q33738349-83398FA7-F377-46F2-BD6B-D06FABD472B5

P1476

Q33738349-CFF9FC2C-6599-48CB-94D7-A3607B316F9E

P2093

Q33738349-01D3914F-CBB1-4B95-BD73-FF24A903B471

P2860

Q33738349-01D7A5B1-A87D-4641-BD70-3F8170CAF96E

Q33738349-081EC76A-CEB2-4EC1-B1F6-2D01E247DF44

Q33738349-0B0C32BB-59C6-479D-B523-64F9E970E87B

Q33738349-0B67BE35-09AB-4BA0-92CB-20399901F3ED

Q33738349-121C144E-9E82-47B0-8A0F-3EF20298978E

Q33738349-130D30C0-C3F0-451A-946B-3677F093FB05

Q33738349-16343DC1-CE62-4DF4-A104-482019F45619

Q33738349-1C822D72-75B9-45BF-A9D7-F84CE73CFC44

Q33738349-229216F7-00F9-4E2C-AD31-ABE00FE68DC9

Q33738349-252EFF99-9612-4FFF-9A87-1A15CF75DBD3

P2888

Q33738349-A1B34FF6-FE3E-4BF6-90E7-1512B4D461D5

P304

Q33738349-7356D1CB-698B-4672-AB07-B5BE54CE4C87

P31

Q33738349-484D33D6-4114-4AC9-83BE-CA0AC1B614A4

P356

Q33738349-ECADDB69-5D27-46B9-902E-A3264E59AFAF

P433

Q33738349-478EBEBD-3BFC-45D2-80D6-E8E72537D055

P478

Q33738349-F2FECD84-E45B-4521-8168-D10598A07018

P577

Q33738349-367694E9-ED63-46E9-B7BA-9268D17172CE

P5875

Q33738349-4A99C797-3FF3-4061-8DFB-968F0F55D06B

P6179

Q33738349-7D001910-D0F6-47BE-BBE7-E7EA5F1E1832

P698

Q33738349-556FB4C9-8DE3-4CE4-BE59-2C8CA0F21F2B

P932

Q33738349-F0924C0B-5EA8-4CF5-B4FD-99B2BD6C56C3

P356

S00213-009-1626-0

P1433

Psychopharmacology

P1476

The 5-HT7 receptor and disorders of the nervous system: an overview.

@en

P2093

Peter B Hedlund

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase

Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation

Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo

SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats

A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

Studies on the neuroendocrine role of serotonin

Tetrahydrobenzindoles: selective antagonists of the 5-HT7 receptor

Presence of a 5-HT7 receptor positively coupled to adenylate cyclase activation in human granulosa-lutein cells

Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes

P2888

s00213-009-1626-0

P304

345-354

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00213-009-1626-0

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

206

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26711978

http://www.w3.org/2001/XMLSchema#string

P6179

1046359185

http://www.w3.org/2001/XMLSchema#string

P698

19649616

http://www.w3.org/2001/XMLSchema#string

P932

2841472

http://www.w3.org/2001/XMLSchema#string